Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Montesi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Translational Medicine|May 7, 2024
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approachGiorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Journal of Translational Medicine|November 29, 2025
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIVJacopo Polvere, Simone Lucchesi, Giorgio Montesi, et al.
Microbiology Spectrum|March 24, 2026
<i>In vitro</i> cellular tropism and immunomodulatory response to rVSVΔG-ZEBOV-GP in human cells derived from tissues associated with adverse eventsPaola Martinez-Murillo, Catia Alvarez, Francesco Santoro, et al.
Frontiers in Immunology|May 15, 2025
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patientsSimone Lucchesi, Giorgio Montesi, Jacopo Polvere, et al.
Biodata Mining|June 11, 2026
TENTACLES: a consensus machine learning tool for robust biomarker discovery in heterogeneous dataGiorgio Montesi, Gabriel Dos Santos Mouta, Maria Novedrati, et al.
Communications Medicine|July 8, 2025
Machine learning approaches to dissect hybrid and vaccine-induced immunityGiorgio Montesi, Simone Costagli, Simone Lucchesi, et al.
Cells|July 14, 2023
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA VaccineAnnalisa Ciabattini, Gabiria Pastore, Simone Lucchesi, et al.
Expert Review of Vaccines|March 22, 2024
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variantGabiria Pastore, Jacopo Polvere, Fabio Fiorino, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2024
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasisBrima M Younis, Rebecca Wiggins, Eltahir A G Khalil, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Translational Medicine|May 7, 2024
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approachGiorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Journal of Translational Medicine|November 29, 2025
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIVJacopo Polvere, Simone Lucchesi, Giorgio Montesi, et al.
Microbiology Spectrum|March 24, 2026
<i>In vitro</i> cellular tropism and immunomodulatory response to rVSVΔG-ZEBOV-GP in human cells derived from tissues associated with adverse eventsPaola Martinez-Murillo, Catia Alvarez, Francesco Santoro, et al.
Frontiers in Immunology|May 15, 2025
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patientsSimone Lucchesi, Giorgio Montesi, Jacopo Polvere, et al.
Biodata Mining|June 11, 2026
TENTACLES: a consensus machine learning tool for robust biomarker discovery in heterogeneous dataGiorgio Montesi, Gabriel Dos Santos Mouta, Maria Novedrati, et al.
Communications Medicine|July 8, 2025
Machine learning approaches to dissect hybrid and vaccine-induced immunityGiorgio Montesi, Simone Costagli, Simone Lucchesi, et al.
Cells|July 14, 2023
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA VaccineAnnalisa Ciabattini, Gabiria Pastore, Simone Lucchesi, et al.
Expert Review of Vaccines|March 22, 2024
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variantGabiria Pastore, Jacopo Polvere, Fabio Fiorino, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2024
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasisBrima M Younis, Rebecca Wiggins, Eltahir A G Khalil, et al.
Pageof 1